.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
QuintilesIMS
Merck
McKesson
US Army
Mallinckrodt
Colorcon
Dow
US Department of Justice

Generated: November 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078338

« Back to Dashboard
NDA 078338 describes CLOTRIMAZOLE, which is a drug marketed by Teva, Glenmark Pharms, Fougera Pharms, Taro, Paddock Llc, Actavis Mid Atlantic, and West-ward Pharms Int, and is included in fifteen NDAs. It is available from twenty suppliers. Additional details are available on the CLOTRIMAZOLE profile page.

The generic ingredient in CLOTRIMAZOLE is betamethasone dipropionate; clotrimazole. There are sixty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; clotrimazole profile page.

Summary for 078338

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details

Pharmacology for NDA: 078338

Ingredient-typeAzoles

Suppliers and Packaging for NDA: 078338

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOTRIMAZOLE
clotrimazole
CREAM;TOPICAL 078338 ANDA E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. 0168-0133 0168-0133-15 15 g in 1 TUBE (0168-0133-15)
CLOTRIMAZOLE
clotrimazole
CREAM;TOPICAL 078338 ANDA E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. 0168-0133 0168-0133-30 30 g in 1 TUBE (0168-0133-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength1%
Approval Date:Sep 2, 2008TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Deloitte
Covington
Teva
Fish and Richardson
Queensland Health
US Department of Justice
Baxter
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot